These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24956251)

  • 1. Assessment of CYP450 genetic variability effect on methadone dose and tolerance.
    Tsai HJ; Wang SC; Liu SW; Ho IK; Chang YS; Tsai YT; Lin KM; Liu YL
    Pharmacogenomics; 2014 May; 15(7):977-86. PubMed ID: 24956251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
    Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G
    Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
    Yang HC; Chu SK; Huang CL; Kuo HW; Wang SC; Liu SW; Ho IK; Liu YL
    PLoS Genet; 2016 Mar; 12(3):e1005910. PubMed ID: 27010727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort.
    Wang SC; Ho IK; Tsou HH; Liu SW; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Liu SC; Wu HY; Kuo HW; Chen AC; Chang YS; Liu YL
    OMICS; 2013 Oct; 17(10):519-26. PubMed ID: 24016178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.
    Chen CH; Wang SC; Tsou HH; Ho IK; Tian JN; Yu CJ; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Lin KM; Hsu YT; Liu SC; Chen ACh; Liu YL
    Pharmacogenomics; 2011 Oct; 12(10):1397-406. PubMed ID: 21902501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision therapeutic opioid dosing implications from genetic biomarkers and craving score.
    Chang HW; Ho WC; Huang CL; Wang RY
    Medicine (Baltimore); 2020 May; 99(22):e20429. PubMed ID: 32481444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
    Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
    PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
    Peles E; Schreiber S; Hetzroni T; Adelson M; Defrin R
    J Pain; 2011 Jan; 12(1):41-50. PubMed ID: 20561825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele.
    Hwang IC; Park JY; Ahn HY; Kim KK; Suh HS; Ko KD; Kim KA
    Clin Chim Acta; 2014 Jan; 428():77-81. PubMed ID: 24262967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
    Yuce-Artun N; Baskak B; Ozel-Kizil ET; Ozdemir H; Uckun Z; Devrimci-Ozguven H; Suzen HS
    Int J Clin Pharm; 2016 Apr; 38(2):388-94. PubMed ID: 26830411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use.
    Fang CP; Liu TH; Chung RH; Tsou HH; Kuo HW; Wang SC; Liu CC; Liu SC; Chen ACH; Liu YL
    PLoS One; 2020; 15(6):e0234549. PubMed ID: 32555608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CYP2C19 variants on methadone metabolism in vitro.
    Lan T; Yuan LJ; Hu XX; Zhou Q; Wang J; Huang XX; Dai DP; Cai JP; Hu GX
    Drug Test Anal; 2017 Apr; 9(4):634-639. PubMed ID: 27199033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy.
    Chen YJ; Lu JT; Huang CW; Wu WH; Lee KF; Liu HT; Shih-Hsin Wu L
    Pharmacogenet Genomics; 2022 Jan; 32(1):31-38. PubMed ID: 34380995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.
    Fang CP; Wang SC; Tsou HH; Chung RH; Hsu YT; Liu SC; Kuo HW; Liu TH; Chen ACH; Liu YL
    J Hum Genet; 2020 Apr; 65(4):381-386. PubMed ID: 31907389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.